TLS Science Park
The new Science Park represents the most important project of the TLS Foundation.
The main aim is to offer equipped buildings, services and financing opportunities, thus creating a fertile ground for the development of new biotech companies focused on pharmaceutical, biotech, diagnostic and innovative biomedical technologies. This process, fostering the industrialization of ideas, will be continuously facilitated by a number of potential synergies available at the site where consolidated pharmaceutical companies are located.
The Science Park is positioned in Siena in the historical area of "Torre Fiorentina", where the prestigious Istituto Sclavo started operations in 1904 and where Novartis Vaccines and Diagnostics Srl (www.novartisvaccines.com) has today concentrated its Research & Development activities and part of its vaccine Manufacturing facilities. Since 2002, the area has also been hosting Sienabiotech S.p.A. (www.sienabiotech.it), a fast-growing company focused on drug discovery in the CNS therapeutic area, and the Molecular Biology Department of Siena University. All together, over 350 researchers are currently working at the Torre Fiorentina Campus, which offers state-of-the art technological platforms, scientific equipment and support services.
The Science Park staff is made by a small group of professionals with both scientific and industrial backgrounds, specifically skilled in technology transfer processes and particularly able to support the new companies. For this purpose, the TLS Park will also give access to an internationally recognized panel of experts able to provide advice on a wide range of matters, from drug discovery to business development.
Besides the equipped labs and offices rental, the TLS Science Park provides incubated companies with a full package of services, ranging from General Services, linked to day-to-day research activities, to Consultancy Services in line with company business management needs.
In addition to the services package and in order to facilitate the first three years of operations, the TLS Science Park provides a large number of technology platforms for common use and dedicated scientific equipments inside the bioincubator.
Close cooperation and synergism with research labs of Novartis Vaccines, Sienabiotech and Siena University located at the campus are strongly encouraged and pursued, as well as international collaborations with excellence centres in the life sciences sector around the world. 14
The main aim is to offer equipped buildings, services and financing opportunities, thus creating a fertile ground for the development of new biotech companies focused on pharmaceutical, biotech, diagnostic and innovative biomedical technologies. This process, fostering the industrialization of ideas, will be continuously facilitated by a number of potential synergies available at the site where consolidated pharmaceutical companies are located.
The Science Park is positioned in Siena in the historical area of "Torre Fiorentina", where the prestigious Istituto Sclavo started operations in 1904 and where Novartis Vaccines and Diagnostics Srl (www.novartisvaccines.com) has today concentrated its Research & Development activities and part of its vaccine Manufacturing facilities. Since 2002, the area has also been hosting Sienabiotech S.p.A. (www.sienabiotech.it), a fast-growing company focused on drug discovery in the CNS therapeutic area, and the Molecular Biology Department of Siena University. All together, over 350 researchers are currently working at the Torre Fiorentina Campus, which offers state-of-the art technological platforms, scientific equipment and support services.
The Science Park staff is made by a small group of professionals with both scientific and industrial backgrounds, specifically skilled in technology transfer processes and particularly able to support the new companies. For this purpose, the TLS Park will also give access to an internationally recognized panel of experts able to provide advice on a wide range of matters, from drug discovery to business development.
Besides the equipped labs and offices rental, the TLS Science Park provides incubated companies with a full package of services, ranging from General Services, linked to day-to-day research activities, to Consultancy Services in line with company business management needs.
In addition to the services package and in order to facilitate the first three years of operations, the TLS Science Park provides a large number of technology platforms for common use and dedicated scientific equipments inside the bioincubator.
Close cooperation and synergism with research labs of Novartis Vaccines, Sienabiotech and Siena University located at the campus are strongly encouraged and pursued, as well as international collaborations with excellence centres in the life sciences sector around the world. 14